(Q56873794)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

R E Eliaz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Wallach

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1546-1550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

Long-term protection against the effects of tumour necrosis factor by controlled delivery of the soluble p55 TNF receptor.

6 November 2019

cites work

1 reference

12 December 2020

Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection

1 reference

12 December 2020

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

12 December 2020

Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients

1 reference

12 December 2020

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

12 December 2020

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

12 December 2020

LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma

1 reference

12 December 2020

Evaluation of local toxicity after repeated intranasal vaccination of guinea-pigs

1 reference

12 December 2020

Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins

1 reference

12 December 2020

Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors

1 reference

12 December 2020

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

1 reference

12 December 2020

A new injectable carbamazepine solution--antiepileptic effects and pharmaceutical properties

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic response after intranasal administration of diazepam to rabbits

1 reference

12 December 2020

Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions

1 reference

12 December 2020

Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus.

1 reference

12 December 2020

Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy

1 reference

12 December 2020

Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans

1 reference

12 December 2020

Controlled release of microquantities of macromolecules

1 reference

12 December 2020

Cloning of genomic DNA for tumor necrosis factor and efficient expression in CHO cells

1 reference

12 December 2020

Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor

1 reference

12 December 2020

Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1007621512647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11303966%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference